logo-loader
viewEden Research plc

Eden Research welcomes 'emergency use' authorisation for Cedroz in Italy

Sean Smith, chief executive of Eden Research PLC (LON:EDEN), caught up with Proactive's Andrew Scott following the announcement their commercial partner, Eastman Chemical Company, has received a 120-day "emergency use" authorisation from the Italian Ministry of Agriculture for Eden's nematicide formulation - Cedroz.

Smith says during this period, Italy and other member states will continue to process Eastman's request for the authorised use and sale of Cedroz following earlier authorisation by Malta.

Quick facts: Eden Research plc

Price: 7.75 GBX

AIM:EDEN
Market: AIM
Market Cap: £16.06 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research plc named herein, including the promotion by the Company of Eden Research plc in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Boost for Arkle Resources as Glencore takes stake in partner

Headlines from the Proactive UK newsroom. Irish mining junior Arkle Resources (LON:ARK) has received a boost after mining titan Glencore invested C$1mln into its partner on the Stonepark Zinc Project. Arkle holds a 23.44% stake in Stonepark, which lies to the south of an existing Glencore...

on 16/10/19

2 min read